Nina Radosevic, Director of the Platform for Advanced or/and Novel Tissue Analyses (TANYA), shared on LinkedIn:
“ESMO26 has started! Take a look at our ePoster 4696eP which presents real world data on association of histological subtype, TILs, HER2 score, PD-L1 CPS and TROP-2 H-score and pCR in 104 TNBC patients treated by the KEYNOTE-522 regimen in Centre Jean Perrin, from 02/2022 to 04/2024.
The histopathological analyses were performed by Quentin Dissard, during his MD thesis project under my supervision.
We wish to thank to our collaborators Ioana Molnar , Judith Passildas Jahanmohan , Fernando Bazan , Marie-Ange Mouret-Reynier , Xavier Durando and Frederique Penault-llorca, for help and support in conducting the translation study VILLAREAL which provided tissue samples for biomarker assessments.
Real world data are getting increasingly recognized as a precious information for development of novel clinical practices.
If you have performed a similar study, do not hesitate to contact me (by DM or by e-mail, I am not present at the congress) – it would be interesting to compare data and maybe publish them together!”
You may also be interested in: TROPION-Breast02: Datopotamab Deruxtecan Shows Intracranial Activity in TNBC With Brain Metastases
